Welcome to your Daily Dose of Health Tech Innovation!
Stay ahead with the latest breakthroughs revolutionizing healthcare—from AI diagnostics to remote care solutions.
We bring you expert-curated insights, emerging trends, and must-know updates from the digital health frontier.
Whether you’re a clinician, innovator, or health tech enthusiast, this roundup delivers what matters most.
Let’s dive into the future of health, one innovation at a time.
Carrum and Lyra Partner on Integrated Specialty and Mental Care
Carrum Health, a national leader in value-based Centers of Excellence for specialty care, and Lyra Health, a top provider of workforce mental health solutions, have announced a strategic partnership to integrate their services and fill critical gaps in employer healthcare benefits. This collaboration links Carrum’s specialty care offerings, which include surgical, cancer, and substance use disorder treatment, with Lyra’s behavioral health support, creating a unified approach to care for high-need and high-cost populations. The partnership allows seamless care coordination, ensuring patients receive both specialty treatment and mental health support while helping employers reduce overall healthcare costs.
Strategos Teams Up with Vizient to Boost Healthcare Security
Strategos International, a national leader in safety, security, and risk management for healthcare, has announced a new partnership with Vizient Southern States and Phoenix Health Care Management Services. Through this collaboration, Strategos will deliver specialized training, consulting, and protection services to healthcare organizations affiliated with Vizient Southern States and Phoenix Health Care Management throughout the region. The partnership leverages Strategos’ extensive experience in supporting healthcare networks and its ability to provide comprehensive, trauma-informed safety and security solutions that produce measurable results.
WellSky Launches New AI Capabilities to Automate and Scale Referral Intake
WellSky has introduced new AI-powered referral management workflows designed to help home health and hospice providers streamline intake, handle complex referrals, and efficiently manage increasing patient volumes amid workforce shortages and incomplete data challenges nationwide. The new tools aim to centralize referral operations and improve access to post-acute care by automating early assessment and prioritization of incoming referrals. Bill Miller, Chairman and Chief Executive Officer at WellSky, stated that applying AI to one of the most constrained points in care delivery allows providers to act more quickly, scale responsibly, and better support both patients and clinicians.
Innovaccer Showcases AI Platforms at Xccelerate 2026 Summit
Innovaccer, a leading healthcare AI company, recently wrapped up Xccelerate 2026, its annual industry and customer conference, bringing together executives, clinicians, policymakers, and technology leaders to address the mounting pressures on the healthcare system. The event focused on how organizations can meet growing patient demand despite workforce shortages, rising operational costs, and increasing administrative complexity. Over two days of discussions, participants explored how financial pressures, regulatory requirements, and inefficient processes are driving healthcare leaders to rethink how work gets done. A key takeaway from the conference was that incremental automation and point AI tools are no longer sufficient to manage the growing gap between workforce capacity and patient needs.
Pilot Program Launches for Nondrug Emotion Regulation Therapy
As the U.S. mental health system struggles with ongoing funding uncertainty, workforce burnout, and growing demand for rapid nonpharmaceutical support, JOYELY, LLC is launching a new emotional regulation pilot program in California this February. With traditional mental health services under strain, scalable tools for managing emotions without medication are increasingly essential.
Fujirebio Launches Automated Lumipulse pTau 217 CSF Assay
H.U. Group Holdings Inc., together with its wholly owned subsidiary Fujirebio, has announced the availability of the Lumipulse G pTau 217 CSF assay designed for use on the fully automated LUMIPULSE G immunoassay analyzers. The new assay uses chemiluminescent enzyme immunoassay technology and is offered for Research Use Only. It enables the quantitative measurement of tau protein phosphorylated at threonine 217 in human cerebrospinal fluid, delivering results in approximately 35 minutes.
To share your insights, please write to us at sudipto@intentamplify.com
